Abstract: |
We thank Lemaitre et al for their letter regarding our manuscript describing the association between intrapatient variability (IPV) of tacrolimus (TAC) trough levels and long-term outcomes in heart transplant (HTx) patients. Indeed, in our study we found that high TAC through level variability at 3-12 months post-HTx was associated with higher rates of graft rejection at odds ratio (OR) of 8.52. However, we wish to clarify that due to the wide 95% confidence interval (1.63-44.53), the minimum odds might also be 1.63 and hence prefer not to define the risk of high TAC through level variability as "tremendous" . This article is protected by copyright. All rights reserved. |